Localization Abilities of Cochlear Implant Recipients in Cases of Single-Sided Deafness by Dillon, Margaret T. et al.
Localization Abilities of Cochlear Implant Recipients in Cases of Single-Sided Deafness
Katharina Burton, BS, BA1; Meredith L Anderson, AuD2; Margaret T Dillon, AuD2
1. Department of Speech and Hearing Sciences, University of North Carolina at Chapel Hill, NC, USA
2. Department of Otolaryngology/Head & Neck Surgery, University of North Carolina at Chapel Hill, NC, USA 
Background
Aim
Methods
Results
Conclusions References
Figure 1: Image of the 11-speaker array
Thirteen (13) subjects were enrolled and received a cochlear implant (CI) as part of the clinical trial investigating cochlear implantation in cases of single-sided 
deafness. All subjects were implanted with the MED-EL Concert standard electrode array and were fit with the Opus 2 external speech processor. All subjects were 
mapped with the FS4 signal coding strategy. Demographic information for this cohort are listed in Table 1. 
Single-Sided Deafness (SSD) can be defined as moderate-to-profound sensorineural hearing loss 
with limited speech perception benefit in one ear and normal hearing in the contralateral ear. 
Despite the presence of one normal hearing ear, SSD patients typically experience difficulty with 
localization1 and understanding speech in noise2,3, in addition to a reduced quality of life4. Current 
hearing technology options for patients with SSD include contralateral routing of the signal 
(CROS) hearing aids and bone conduction devices.
The main advantage of CROS hearing aids and bone conduction devices is the ability for the 
patient to hear sounds coming from the affected side. However, both of these technologies send the 
signal to the normal hearing ear, which keeps the patient in a unilateral listening condition. This 
results in the inability to take advantage of binaural listening cues to help improve speech 
understanding in noise and localization of sounds in the environment5. Stimulation of the auditory 
pathway on the affected ear could provide binaural cues to SSD patients. 
Cochlear implantation may provide a benefit over the current hearing technology options for SSD, 
as it stimulates the auditory pathway on the affected side. This may permit bilateral stimulation of 
the auditory pathway, potentially allowing the patient to take advantage of binaural cues to improve 
speech understanding in noise, localization, and quality of life. 
There was no difference in localization abilities between the unaided and BCHA conditions at 
the preoperative interval. Subjects experienced a significant improvement in rms error when 
listening with a cochlear implant plus the normal hearing ear as compared to preoperative 
listening conditions. The subjective benefit measured with the SSQ questionnaire reflected 
these findings.
Patients with unilateral hearing loss who meet cochlear implantation candidacy criteria on the 
affected side may experience improvements in localization abilities with the use of a cochlear 
implant.
To assess whether cochlear implant subjects with SSD experience 
subjective and objective improvements in localization
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Inclusion Criteria: 
• Affected ear: moderate-to-profound 
sensorineural hearing loss
• Aided CNC word score < 60% in the ear 
to be implanted
• Contralateral ear: normal-to-mild hearing
• > 18 years of age at implantation
• Duration of moderate-to-profound hearing 
loss < 10 years
• Completion of at least a 1-month trial 
with hearing technology
• Realistic expectations
• No reported cognitive issues
Exclusion Criteria: 
• Conductive hearing loss
• Compromised auditory nerve
• Cochlear ossification
• Sudden HL that has not been evaluated by 
a physician
• Tinnitus as primary reason for seeking CI
All subject received their cochlear implant as part of a FDA clinical trial investigating 
cochlear implantation in cases of Single-Sided Deafness.
Listening Conditions: 
• Unaided (contra ear only)
• Bone-conduction hearing aid (BCHA) plus 
contra ear 
• Cochlear implant (CI) + contra ear 
(CI+Contra)
Assessment Intervals: 
• Preoperative evaluation 
• 1-month post-initial activation
• 3-months post-initial activation
• 6-months post-initial activation
• 9-months post-initial activation
Localization Task: 
• 11-speaker array (Figure 1)
• Subject seated 1 meter away facing  
speaker #6 
• 200 ms speech noise bursts
• Varying intensity level (60, 70 & 80 dB SPL)
• Subject verbalized speaker number
• No feedback provided
Figure 2: Localization results for each subject at the preoperative, 1-month,     
3-month, 6-month, and 9-month follow-up intervals.
At the preoperative interval subjects were 
tested in two conditions: 1) unaided, and 2) 
with a bone-conduction hearing aid 
(BCHA; BAHA Intenso on a test band). 
During follow-up intervals, subjects were 
tested with their CI plus the normal hearing 
ear (CI+contra) to assess whether the 
addition of the CI improved localization 
abilities. Ten (10) normal hearing subjects 
completed the test battery for a 
performance comparison. 
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Table 1: Demographic information for the 13 subjects who 
completed the 9-month follow-up interval.
The difference between the sound source and the response on each trial was reported in root-mean-square (rms) error, where a lower value is indicative of better 
performance. Initial results between conditions were compared using a Welch’s t-test, with α<0.05. There was no difference in the rms error between the unaided and 
BCHA conditions (p=0.24) at the preoperative interval. There was a significant difference between the preoperative unaided condition and the CI+contra condition after 
1-month (p<0.001) of listening experience with the CI. Subjects also reported a significant improvement in localization abilities between the preoperative and 1-month 
follow-up interval on the speech (p<0.001) and spatial (p<0.001) subscales on the Speech, Spatial and Qualities (SSQ) questionnaire.
Demographic Max Min Average
Duration of Hearing 
Loss
6.6 0.3 2.6
Age at Implantation 66.0 22.6 48.8
Figure 3: Subjective results on SSQ for all subjects at the preoperative, 1-month, 
3-month, 6-month, and 9-month follow-up intervals.
